Health Media Articles

Excerpts of Key Health Media Articles in Major Media

Below are key excerpts of revealing news articles on health from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

For further exploration, delve into our comprehensive Health and Food Corruption Information Center.

Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.

While drug use is a problem among industrial workers nationwide, it raises particular concern in the oil patch as U.S. production surges to record levels in what is already one of the nation’s most dangerous sectors - with a fatality rate about three times the average for other industries. Drug use is a significant factor in workplace injuries and crimes involving oilfield workers, according to drug counselors, hospital and police officials and court records in West Texas, the epicenter of the U.S. shale sector. As the shale revolution has spawned waves of hiring here since 2010, law enforcement authorities have tracked a boom in drug trafficking and related crime. In Midland and Ector counties, home to many Permian Basin oil workers, state and local police in 2016 seized more than 95 pounds of methamphetamine - up from less than four pounds in 2010. Despite corporate and regulatory efforts to curb drug abuse, many oilfield workers regularly use stimulants on long shifts of grueling work for relatively high pay. When oil jobs are plentiful, companies desperate for labor sometimes will disregard signs of substance abuse, said three recovering drug addicts who worked in the oilfield. “These oilfield bosses - they party, too,” [oilfield worker] Forsythe said. “As long as you’re getting the job done and not making a scene, they won’t drug test you.”

Note: The above article links to this graphic on illegal drugs shadow oil boom. For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and health.

When it comes to treating cancer, surgeons want to get rid of as much cancerous tissue as possible during tumor removal. Now a new technology - the size of a pen - is attempting to make that easier by distinguishing between tumors and healthy tissue in just 10 seconds. The MasSpec Pen is a real-time diagnostic tool created by researchers at the University of Texas at Austin. In a new study published Wednesday in the journal Science Translational Medicine, the researchers report that their handheld device (which is not yet FDA-approved) uses tiny droplets of water to analyze human tissue samples for cancer. “It’s a gentle, simple chemical process,” says study author Livia Schiavinato Eberlin. “It’s highly specific and highly sensitive. The fact that it’s non-destructive brings a new approach to cancer diagnosis.” Getting rid of all cancerous tissue while also preventing any harm to healthy tissue is a delicate process. Other tools available to surgeons for tissue diagnosis ... use gases or solvents that can be harmful for the human body [and] are slower than the MasSpec Pen. In the study, the researchers tested 253 human tissue samples from lung, ovary, thyroid and breast cancer tumors and compared them to samples of healthy tissues. The device was 96% accurate at identifying cancerous tissues. The researchers also tested the MasSpec Pen in live mice with tumors and found that the device was able to identify the presence of cancer without harming healthy surrounding tissues.

Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.

More than 50 species of fish have been found to consume plastic trash at sea. This is bad news, not only for fish but potentially also for humans who rely on fish for sustenance. Fish don’t usually die as a direct result of feeding on the enormous quantities of plastic trash floating in the oceans. But that doesn’t mean it’s not harmful for them. Some negative effects that scientists have discovered when fish consume plastic include reduced activity rates and weakened schooling behavior, as well as compromised liver function. Most distressingly for people, toxic compounds that are associated with plastic transfer to and bioaccumulate in fish tissues. This is troubling because these substances could further bio­accumulate in people who consume fish that have eaten plastic. Plastic trash poses a serious threat to marine animals, but we are still trying to understand why animals eat it. Typically, research has concluded that marine animals visually mistake plastic for food. While this may be true, the full story is probably more complex. For example, colleagues at the University of California at Davis and I showed in a recent study that plastic debris may smell attractive to marine organisms. That’s a problem, because if plastic looks and smells interesting to fish, it will be very hard for them to discern that it is not food.

Note: For more along these lines, see concise summaries of deeply revealing news articles on food system corruption and health.

After years of lobbying and experimental research, the FDA has granted "breakthrough therapy" status for the drug MDMA as a potential treatment for post-traumatic stress disorder. The designation does not mean the drug is FDA-approved, but it does ease the way for clinical trials to test its safety and effectiveness in patients with PTSD. The non-profit Multidisciplinary Association for Psychedelic Studies (MAPS), which has been advocating and fundraising for MDMA research for three decades, announced the FDA's designation. More commonly known as its street names ecstasy or Molly, MDMA (methylenedioxymethamphetamine) is a psychoactive drug that produces feelings of energy and euphoria, often followed by an emotional crash. In recent years, some in the scientific community have suggested it could have medical benefits, as well. In previous phases of clinical trials, the drug was shown to offer significant relief to sufferers of PTSD, a mental health disorder characterized by nightmares or flashbacks and heightened anxiety or depression after experiencing or witnessing a terrifying event. In phase 2 clinical trials sponsored by MAPS, 61 percent of the 107 participants with chronic, treatment-resistant PTSD no longer had the disorder after two months of MDMA-assisted psychotherapy treatment. At a 12-month follow up, 68 percent no longer had PTSD. The organization expects to begin phase 3 trials with a larger group of participants next year.

Note: For more along these lines, see concise summaries of deeply revealing news articles on mind-altering drugs from reliable major media sources.

For Jon Lubecky, the scars on his wrists are a reminder of the years he spent in mental purgatory. He returned from an Army deployment in Iraq a broken man. He got every treatment offered by Veterans Affairs for post-traumatic stress disorder. But they didn’t stop him from trying to kill himself - five times. Finally, he signed up for an experimental therapy and was given a little green capsule. The anguish stopped. Inside that pill was the compound MDMA, better known ... as ecstasy. That street drug is emerging as the most promising tool in years for the military’s escalating PTSD epidemic. The MDMA program was created by a small group of psychedelic researchers who had toiled for years in the face of ridicule, funding shortages and skepticism. But the results have been so positive that this month the Food and Drug Administration deemed it a “breakthrough therapy” - setting it on a fast track for review and potential approval. Only two drugs are approved for treating PTSD: Zoloft and Paxil. Both have proved largely ineffective. By giving doses of MDMA at the beginning of three, eight-hour therapy sessions, researchers say they have helped chronic PTSD patients process and move past their traumas. In clinical trials with 107 patients closely monitored by the FDA, 61 percent reported major reductions in symptoms - to the point where they no longer fit the criteria for PTSD. Follow-up studies a year later found 67 percent no longer had PTSD.

Note: Read more about how MDMA has been found effective for treating PTSD in a therapeutic context. Articles like this suggest that the healing potentials of mind-altering drugs are gaining mainstream scientific credibility.

Truth Initiative, a leading tobacco-control nonprofit, has bought TV ads to run this Sunday during MTVs Music Awards that accuse tobacco companies of purposely targeting mentally ill people and U.S. soldiers. The ads focus on this stark but little known fact: Roughly 40 percent of cigarettes sold in the U.S. are smoked by people with mental health issues, including depression, anxiety or substance-abuse problems. The ads also note that 38 percent of military smokers start after enlisting. Robin Koval, chief executive of Truth Initiative, accused tobacco companies of exploiting the mentally ill and military for profit. The latest ads from Truth cite internal tobacco industry documents that discuss ways to make inroads into the mentally ill population. They note that tobacco companies even distributed free cigarettes to psychiatric facilities at one point, and tried to sell the idea that they would help steady patients nerves. For years, experts say, psychiatrists and therapists often resisted counseling their patients to quit smoking. Their reasoning was that patients would be overburdened by trying to quit smoking. [A] change in approach has begun to spark new partnerships and joint programs between tobacco-control groups and groups like the National Alliance for Mental Illness. At the same time, concern has also increased about smoking among military service members, because of the [young] age when most enlist.

Note: For more along these lines, see concise summaries of deeply revealing corporate corruption news articles from reliable major media sources.

Baby Boomers are sucking the blood of the young. They are ... after the plasma. In Monterey, California, a new startup has emerged, offering transfusions of human plasma: 1.5 litres a time, pumped in across two days, harvested uniquely from young adults. Ambrosia, the vampiric startup concerned, is run by a 32-year-old doctor called Jesse Karmazin, who bills $8,000 (6,200) a pop for participation in what he has dubbed a study. So far, he has 600 clients, with a median age of 60. The blood is collected from local blood banks, then separated and combined it takes multiple donors to make one package. The idea has become faddish in tech circles. Mike Judges Silicon Valley sitcom recently parodied the notion, with arch-tech guru Gavin Belson relying on a blood boy following him around to donate pints of sticky red at inopportune moments. That fictionalised account may well be based on the real-life adventures of Peter Thiel, the PayPal founder. A 2014 Harvard report ... seems to have kickstarted the present revival of interest in transfusions. There, scientists injecting old mice with the plasma of a younger generation found it improved their memory and their ability to learn. Conversely, injecting old blood into young seemed to knobble the young rodents. The scientific community has rolled its eyes at the trial element of Ambrosia. There is no control group and, with participation costing so much, no one involved is very randomised.

Note: Read more about Silicon Valley billionaire Peter Thiel's investment in this questionable technology. One university researcher has found that many in the European royalty until the end of the 18th century practiced selective cannibalism in the belief if would keep them young. Another article goes into greater depth about the practice some elder members of the wealthy elite taking blood infusions from young people to stay young.

Scientists in the U.S. and India have found an inexpensive treatment that could possibly save hundreds of thousands of newborns each year. And it turns out, the secret weapon was sitting in Asian kitchens all along: probiotic bacteria that are common in kimchi, pickles and other fermented vegetables. Feeding babies the microbes dramatically reduces the risk newborns will develop sepsis, scientists report ... in the journal Nature. Sepsis is a top killer of newborns worldwide. Each year more than 600,000 babies die of the blood infections. "All the sudden the baby stops being active. It stops crying and breastfeeding," says Dr. Pinaki Panigrahi, a pediatrician ... who led the study. For the past 20 years, Panigrahi has been working on a way to prevent sepsis. The tricky part, Panigrahi says, was figuring out the best strain of bacteria to protect against sepsis. "We screened more than 280 strains," Panigrahi says. "So it was a very methodical process." In the end, the one that seemed the most promising was a strain of lactobacillus plantarum. So Panigrahi and his team decided to move forward with a large-scale study. They were shocked by how well the bacteria worked. Babies who ate the microbes for a week ... had a dramatic reduction in their risk of death and sepsis. They dropped by 40 percent, from 9 percent to 5.4 percent. But that's not all. The probiotic also warded off several other types of infections, including those in the lungs. Respiratory infections dropped by about 30 percent. A course of the probiotic costs about $1 per baby.

Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.

The sperm count of men in Western countries has been declining precipitously with no signs of “leveling off,” according to new research, bolstering a school of thought that male health in the modern world is at risk, possibly threatening fertility. An international team of researchers ... looked at semen samples from 42,935 men from 50 countries from 1973 to 2011. They found that sperm concentration - the number of sperm per milliliter of semen - had declined each year, amounting to a 52.4 percent total decline, in men from North America, Europe, Australia and New Zealand. Total sperm count among the same group also tumbled each year for a total decline of 59.3 percent over the nearly 40-year period. Decreasing sperm count was first reported a quarter century ago, but the new analysis shows that “this decline is strong and continuing,” said Dr. Shanna H. Swan, one of the study’s authors. A 2005 study, Dr. Swan said, showed that prenatal exposure to phthalates, also called plasticizers, affected the development of sons. Phthalates are a group of chemicals used to make plastics more flexible and harder to break. They have been shown to disrupt the operation of male hormones like testosterone and have been linked to genital birth defects in male infants. Professor Skakkebaek, an author of a 1992 study that suggested chemicals play a role in the steady decline in semen quality, has since indicated that a rise in abnormal male reproductive systems may be linked to exposures to endocrine-disrupting chemicals.

Note: Exposure to endocrine-disrupting chemicals has also been linked to "lower IQ, adult obesity and 5% of autism cases". For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources.

Why do Americans continue to pay the highest prices for medicine in the world? Lawmakers have sculpted specific policies, often not found in many other nations, that boost pharmaceutical industry profits. Meanwhile, the drug industry has spent $61 million on state elections and nearly $67 million on federal elections since 2010. Both parties have made pivotal decisions ... that have kept drug prices high. Insurance companies and pharmacy benefit managers, or PBMs, across the U.S., face at least nine class-action lawsuits alleging they attached arbitrary premiums to the prices of often less-expensive, generic prescription drugs. The plaintiffs also accuse the PBMs and insurers of imposing so-called “gag clauses” on pharmacies to keep pharmacists from telling consumers that they could save money by paying out of pocket. The system could be denying customers $120 billion in discounts and rebates. Should drugs developed at taxpayer expense be sold to Americans at sky high prices? In the past, the federal government passed a rule saying no — but that rule was rescinded in 1995. If Americans were allowed to import lower-priced drugs from places like Canada, it would save government agencies alone $6 billion. But ... Americans are still prohibited from engaging in such importation. The federal government could [also] save billions of dollars a year by having Medicare use its huge market power to negotiate - or require - lower drug prices for the program's beneficiaries.

Note: For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma profiteering and health.

A loud boom cut through the night and a stream of fire lit up the sky. A strong, unpleasant odor settled over the street. None of the neighbors reported what happened that night - nor the ... symptoms that followed. For [Joseph] Gaines, the symptoms included an intense sudden headache, tearing eyes, a runny nose, and congestion. A block and a half from Gaines’s house, the street ends in an Exxon Mobil refinery that ... releases at least 135 toxic chemicals, many of which - including 1,3-butadiene, benzo[a]pyrene, and styrene - are carcinogens. The plant is regularly in noncompliance with the Clean Air Act. Yet many of the people [in] Charlton-Pollard said they felt there was no point in trying to reduce the emissions. They raised [their concerns] in a formal complaint to the Environmental Protection Agency 17 years ago. The filing [described] the chemical pollution. And the complaint went further, arguing that the location of the oil refinery - next to a neighborhood where 95 percent of residents were African-American - was a civil rights violation. The majority of civil rights complaints the EPA accepted for investigation between 1996 and 2013 languished for years. As the people of Charlton-Pollard and Flint — as well as Tallassee, Alabama; Pittsburg, California; and Chaves County, New Mexico — can attest, the EPA’s lack of responsiveness to civil rights complaints spans not just many years, but also several presidential administrations. While pollution protections are moving backward, Exxon Mobil is planning to expand its Beaumont operations.

Note: For more along these lines, see concise summaries of deeply revealing news articles on health and the erosion of civil liberties.

How much proper brainwork – not zoning out in meetings, or reorganising the stationery cupboard, but work that involves really thinking – should you aim to get done in one day? The answer isn’t some sophisticated version of: “It depends.” The answer is four hours. That, anyway, is the persuasive conclusion reached by Alex Pang in his book Rest: Why You Get More Done When You Work Less. This column has evangelised before about the truth of that subtitle, what with the nine-to-five being a relic of the industrial revolution with no relevance to modern “knowledge work” – but what’s so striking about Pang’s argument is its specificity. Ranging across history and creative fields, he keeps encountering the same thing. Charles Darwin worked for two 90-minute periods in the morning, then an hour later on; the mathematician Henri Poincaré from 10am till noon then 5pm till 7pm; the same approximate stretch features in the daily routines of Thomas Jefferson, Alice Munro, John le Carré and many more. And maybe it’s not just creative work. Half a century ago, the anthropologist Marshall Sahlins caused a stir by suggesting that people in hunter-gatherer societies aren’t ceaselessly struggling for survival; on the contrary, they’d built “the original affluent society”, by keeping their needs low, then meeting them. Crunching numbers from Africa and Australia, he calculated the average number of hours hunter-gatherers must work per day, to keep everyone fed. That’s right: it was “three to five hours”. Don’t you think it’s time we took the hint?

Note: For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources.

Pressure to feel upbeat can make you feel downbeat, while embracing your darker moods can actually make you feel better in the long run, according to new UC Berkeley research. "We found that people who habitually accept their negative emotions experience fewer negative emotions, which adds up to better psychological health," said study senior author Iris Mauss. "Maybe if you have an accepting attitude toward negative emotions, you're not giving them as much attention," Mauss said. "And perhaps, if you're constantly judging your emotions, the negativity can pile up." The study ... tested the link between emotional acceptance and psychological health in more than 1,300 adults. People who commonly resist acknowledging their darkest emotions, or judge them harshly, can end up feeling more psychologically stressed. By contrast, those who generally allow such bleak feelings as sadness, disappointment and resentment to run their course reported fewer mood disorder symptoms than those who critique them or push them away, even after six months. "It turns out that how we approach our own negative emotional reactions is really important for our overall well-being," said study lead author Brett Ford. "People who accept these emotions without judging or trying to change them are able to cope with their stress more successfully."

Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.

About one out of every 12 U.S. doctors gets money, lunch or something else of value from companies that make opioid drugs, researchers reported Wednesday. Companies are spending much more time and effort marketing opioids to doctors than they are other, less addictive painkillers, the researchers found. They say their findings help explain why doctors have played such an important role in the opioid overuse epidemic. “A large proportion of physicians received payments - one in 12 physicians overall,” said Dr. Scott Hadland of the Boston Medical Center. “Tens of millions of dollars were transferred for marketing purposes for opioids. In some cases they are money provided directly to physicians - for example, the speaking fees, the consultant fees and the honoraria. In other cases it is reimbursement for things like travel,” Hadland said. Between 2013 and 2015, the team found 375,266 payments worth $46 million made to more than 68,000 doctors. “The top 1 percent of physicians (681 of them) received 82.5 percent of total payments in dollars,” the team wrote in their report. A study published last year found that physicians who accepted even one meal sponsored by a drug company were much more likely to prescribe a name-brand drug to patients later. The Centers for Disease Control and Prevention says doctors are definitely helping drive the addiction crisis. The result is deadly. More than 30,000 Americans died from opioid overdoses in 2015.

Note: The city of Everett, Washington is currently suing Purdue Pharma, maker of the opioid pain medication OxyContin, for the company's alleged role in the diversion of its pills to black market buyers. For other reliable information on pharmaceutical involvement in the huge increase in opioid deaths, see Dr. Mercola's excellent article. For more along these lines, see concise summaries of deeply revealing pharmaceutical corruption news articles from reliable major media sources.

As the U.S. growing season entered its peak this summer, farmers began posting startling pictures on social media: fields of beans, peach orchards and vegetable gardens withering away. The photographs served as early warnings of a crisis that has damaged millions of acres of farmland. New versions of the herbicide dicamba developed by Monsanto and BASF, according to farmers, have drifted across fields to crops unable to withstand it. As the crisis intensifies, new details provided to Reuters ... demonstrate the unusual way Monsanto introduced its product. The approach, in which Monsanto prevented key independent testing of its product, went unchallenged by the Environmental Protection Agency and nearly every state regulator. Typically, when a company develops a new agricultural product, it commissions its own tests and shares the results and data with regulators. It also provides product samples to universities for additional scrutiny. In this case, Monsanto denied requests by university researchers to study its XtendiMax with VaporGrip for volatility - a measure of its tendency to vaporize and drift across fields. Monsanto provided samples of XtendiMax before it was approved by the EPA. However, the samples came with contracts that explicitly forbade volatility testing. Arkansas blocked Monsanto’s product because of the lack of extra volatility testing ... but approved BASF’s [product]. Thirty-three other states - every other state where the products were marketed - approved both products.

Note: A new project called "The Poison Papers" lays out a 40-year history of deceit and collusion involving the chemical industry and the regulatory agencies that were supposed to be protecting human health and the environment. For more along these lines, see concise summaries of deeply revealing food system corruption news articles from reliable major media sources.

Martin Shkreli - famously known as the guy that jacked up the price of a lifesaving AIDS treatment by 5,000% - finally saw his day in court, albeit for a completely unrelated case involving an unrelated company. The trial ... found Shkreli guilty of three counts of fraud for essentially lying to his investors about how he would invest their money and when they would be paid back. The conviction, carrying a potential 20 years in prison, is no joke. Yet the notorious self-promoter took the opportunity to ... let the world know he wasn’t fazed. And why should he be? How Shkreli got rich in the first place remains not just legal but celebrated. The real crime of the Pharma Bro is the unrepentant greed that drives him, as well as the industry he’s thrived in. Sen. Bernie Sanders has attempted to put a stop to this greed with recently introduced legislation to cap prices for pharmaceuticals developed by government-funded research. Far from a new idea, Sanders has been pushing for a bill like this for decades. While raising the price of a life-saving drug by 5,000% rightfully drew the scorn of millions of people, price gouging is all too common for the industry. Take the EpiPen, the lifesaving device for kids and adults with severe allergies, whose price was famously hiked up over 500% ... after it was acquired by Mylan. Laws that protect investors in these companies are what landed Shkreli in court. Yet until there are laws to protect patients from drug company extortion, like the one proposed by Sanders, the line of Pharma Bros ready to take his place is already queued up.

Note: For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma profiteering and corporate corruption.

A new device developed at The Ohio State University can start healing organs in a "fraction of a second," researchers say. The technology, known as Tissue Nanotransfection (TNT), has the potential to save the lives of car crash victims and even deployed soldiers injured on site. It's a dime-sized silicone chip that "injects genetic code into skin cells, turning those skin cells into other types of cells required for treating diseased conditions," according to a release. And, it not only works on skin cells, it can restore any type of tissue, Chandan Sen, director of the Center for Regenerative Medicine and Cell-Based Therapies, said. For example, the technology restored brain function in a mouse who suffered a stroke by growing brain cells on its skin. This is a breakthrough technology, because it's the first time cells have been reprogrammed in a live body. “This technology does not require a laboratory or hospital and can actually be executed in the field," Sen said. "It’s less than 100 grams to carry and will have a long shelf life.” It is awaiting FDA approval, but Sen, who has been working on this for four years, expects TNT will be tested on humans within the year. He says he's talking with Walter Reed National Medical Center now. "We are proposing the use of skin as an agricultural land where you can essentially grow any cell of interest," Sen said.

Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.

Since 2000, the number of overdose deaths from drugs in the U.S. has risen more than 137%. Deaths from opioids - which include painkillers and heroin - make up a large portion of these deaths; 91 Americans die every day from an opioid overdose. Federal numbers like these reveal a dire situation. But a new study finds that many opioid-related deaths are underreported, and that the full picture of the epidemic may be worse than even those numbers show. In the report, Christopher Ruhm, a professor of public policy & economics at the University of Virginia ... found that nationwide, the death rate from opioids is 24% higher than what has been estimated previously. Deaths related to heroin, which is cheaper than prescription painkillers, are 22% higher, he says. When hospitals enter the cause of death on a person’s death certificate, the drugs that contributed might not be specified, or multiple drugs will be listed as present. Between 20%-25% of the overdose death certificates Ruhm studied did not have any drug specified, suggesting that statewide estimates of deaths linked to opioids could be significantly off. Ruhm found that the overall death rates from opioids were substantially underreported across the U.S. - by more than half in Pennsylvania, for example. The growth in death rates from 2008 to 2014 - the time period Ruhm studied - was also substantially underestimated in many states.

Note: The city of Everett, Washington is currently suing Purdue Pharma, maker of the opioid pain medication OxyContin, for the company's alleged role in the diversion of its pills to black market buyers. For other reliable information on pharmaceutical involvement in the huge increase in opioid deaths, see Dr. Mercola's excellent article. For more along these lines, see concise summaries of deeply revealing pharmaceutical corruption news articles from reliable major media sources.

Americans take more pills today than at any other time in recent history - and far more than people in any other country. Much of that medication use is lifesaving or at least life-improving. But a lot is not. The amount of harm stemming from inappropriate prescription medication is staggering. Almost 1.3 million people went to U.S. emergency rooms due to adverse drug effects in 2014, and about 124,000 died from those events. That’s according to estimates based on data from the Centers for Disease Control and Prevention and the Food and Drug Administration. Other research suggests that up to half of those events were preventable. All of that bad medicine is costly, too. An estimated $200 billion per year is spent in the U.S. on the unnecessary and improper use of medication, for the drugs themselves and related medical costs. Our previous surveys have found that higher drug costs - including more expensive drugs and higher out-of-pocket costs - also strain household budgets, with many people telling us they had to cut back on groceries or delay paying other bills to pay for their prescriptions. Total spending on drug ads targeting consumers reached $6.4 billion last year, 64 percent more than in 2012. That’s $1.3 billion more than the FDA’s entire 2017 budget. Drug companies spend even more - $24 billion in 2012 alone - on marketing just to doctors through ads in medical journals, face-to-face sales, free medication samples, and educational and promotional meetings.

Note: For more, see this informative article . For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma profiteering and health.

Documents released Tuesday in a lawsuit against Monsanto raised new questions about the company’s efforts to influence the news media and scientific research and revealed internal debate over the safety of its highest-profile product, the weed killer Roundup. The active ingredient in Roundup, glyphosate, is the most common weed killer in the world. The documents underscore the lengths to which the agrochemical company goes to protect its image. Documents show that Henry I. Miller ... a vocal proponent of genetically modified crops, asked Monsanto to draft an article for him that largely mirrored one that appeared under his name on Forbes’s website in 2015. An academic involved in writing research funded by Monsanto, John Acquavella, [wrote] in a 2015 email to a Monsanto executive, “I can’t be part of deceptive authorship on a presentation or publication.” He also said of the way the company was trying to present the authorship: “We call that ghost writing and it is unethical.” Mr. Miller’s 2015 article on Forbes’s website was an attack on the findings of ... a branch of the World Health Organization that had labeled glyphosate a probable carcinogen. The documents also show that A. Wallace Hayes, the former editor of a journal, Food and Chemical Toxicology, has had a contractual relationship with Monsanto. In 2013, while he was still editor, Mr. Hayes retracted a key study damaging to Monsanto that found that Roundup, and genetically modified corn, could cause cancer and early death in rats.

Note: For lots more, see this informative article. For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and health.

Important Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.